ARS Pharmaceuticals Inc (SPRY)
ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
Curaleaf Launches Fifth Annual Feed the Block Fundraiser to Combat Food Insecurity Across the U.S.
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
Cybin to Participate at the 2025 Milken Institute Future of Health Summit
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
Dyne Therapeutics to Present at Upcoming Investor Conferences
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences